This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23; On-demand experience Delivered September 28-30Boston Convention and Exhibition Center

Nagendra Singh, Remote - Live with Q&A
Senior Scientist, Downstream Process Development at Catalent Cell & Gene Therapy, USA


Dr. Nagendra Singh has more than 10 years of R&D experience focused on preclinical protein and small molecule drug development. He is currently a Senior Scientist in the Downstream Process Development group within Catalent Cell and Gene Therapy. Nagendra leads and supports preclinical and early stage development and characterization of viral vectors for gene therapy. He holds a Ph.D. in Pharmaceutical Analysis from the University of Sunderland, UK and has completed postdoctoral research at the National Institute on Aging, NIH.

Agenda Sessions

  • ROOM 210B: Evaluation of novel affinity resin with alkali stable ligand for AAV viral vectors